Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Use of metformin against breast cancer

Prof Alastair Thompson – University of Dundee, UK

Use of metformin against breast cancer ( Prof Alastair Thompson – University of Dundee, UK )

Cancer genes differ in different parts of a tumour

Prof Charles Swanton - CRUK London Research Institute and UCL, UK

Cancer genes differ in different parts of a tumour ( Prof Charles Swanton - CRUK London Research Institute and UCL, UK )

Targeting DNA damage response and repair excluding PARP for triple negative...

Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden

Targeting DNA damage response and repair excluding PARP for triple negative breast cancer ( Prof Thomas Helleday - Karolinska Institutet, Stockholm, Sweden )

Molecular characterisation of breast cancer: the mutational landscape

Prof Sam Aparicio - University of British Columbia, Vancouver, Canada

Molecular characterisation of breast cancer: the mutational landscape ( Prof Sam Aparicio - University of British Columbia, Vancouver, Canada )

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer

Prof Richard Finn - Universtity of California, Los Angeles, USA

New cyclin-dependent kinase inhibitor with letrozole for ER+/HER2- breast cancer ( Prof Richard Finn - Universtity of California, Los Angeles, USA )

Metabolism in malignant tumors: a new approach for treating breast cancer

Prof Tak Mak - University of Toronto, Canada

Metabolism in malignant tumors: a new approach for treating breast cancer ( Prof Tak Mak - University of Toronto, Canada )

Criteria required before implementation of whole genome arrays in clinical...

Prof Daniel Hays - University of Michigan, Ann Arbor, USA

Criteria required before implementation of whole genome arrays in clinical practice ( Prof Daniel Hays - University of Michigan, Ann Arbor, USA )

Evidence for TORC1 activation marker as a predictive factor for everolimus...

Dr Thomas Bachelot - Centre Leon Berard, Lyon, France

Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer ( Dr Thomas Bachelot - Centre Leon Berard, Lyon, France )

Prognostic significance of progesterone receptor-positive tumour cells within...

Dr Aleix Prat - University of North Carolina, USA

Prognostic significance of progesterone receptor-positive tumour cells within luminal A breast cancer ( Dr Aleix Prat - University of North Carolina, USA )

EONS 2012 lifetime achievement award

Nurgün Platin – Oncology Nursing Association, Turkey

EONS 2012 lifetime achievement award ( Nurgün Platin – Oncology Nursing Association, Turkey )

Impact and management of malignant wounds

Dr Betina Lund-Nielsen - University of Copenhagen, Denmark

Impact and management of malignant wounds ( Dr Betina Lund-Nielsen - University of Copenhagen, Denmark )

Patient perspective on cancer and pregnancy (Italian)

Silvia Formichetti - Breast Cancer Survivor

Patient perspective on cancer and pregnancy (Italian) ( Silvia Formichetti - Breast Cancer Survivor )

More from ecancer